Aster Dm Healthcare Ltd. · NSE:ASTERDM

Aster Dm Healthcare — Q3 FY20 Earnings Presentation

43 slides from Aster Dm Healthcare's earnings presentation, Feb 11, 2020

  1. Slide 1: Cover letter to stock exchanges

    11 February 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd l51 Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051

  2. Slide 2: Investor Presentation – For the quarter ended 31st December 2019

    Investor Presentation – For the quarter ended 31st December 2019 1

  3. Slide 3: Disclaimer

    Disclaimer  This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit

  4. Slide 4: Aster – Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3

  5. Slide 5: Aster DM Healthcare – Business Overview

    Aster DM Healthcare – Business Overview One of Largest Private CAPACITY BEDS HOSPITALS healthcare service providers GCC: 1,111 GCC: 12 4,804 25 India: 3,693 India: 13 operating in Asia (GCC & India) PATIENT VISITS – FY20 9M Present in 8 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, GCC: ~12.7 m

  6. Slide 6: Aster DM Healthcare – Financial Overview

    Aster DM Healthcare – Financial Overview Revenue - FY209M Revenue - FY209M India 19% Pharmacies INR ~6,437 Cr 26% Hospitals Clinics 51% GCC 81% 23% EBITDA - FY209M EBITDA - FY209M India Pharmacies 20% 19% INR ~652 Cr Clinics Hospitals GCC 25% 56% 80% Note: 1. Revenue and EBITDA shown above excludes

  7. Slide 7: Geographical Footprint

    Geographical Footprint GCC INDIA Hospitals – 12 Hospitals - 13 Clinics – 107 Clinics - 9 Pharmacies - 236 United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Calicut Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women &

  8. Slide 8: Hospitals List

    Hospitals List Commencement/ Bed Operational Ow ned Hospitals - GCC Location Capaci t y Oper at i onal Acquisition Year Capacity Beds /Leased Geogr aphy Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffa Hospital Muscat, Oman 2009 86 72 Leased GCC 1,111 920 Al Raffa Hospital Sohar, Oma

  9. Slide 9: The Aster DM Healthcare Edge

    The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder Differentiated Asset-light Business Model in GCC structure

  10. Slide 10: Aster DM Healthcare - Evolution

    Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 1987: Commenced 2003: Expansion to new geography

  11. Slide 11: Robust Growth Over Last 5 Years

    ROBUST GROWTH OVER LAST 5 YEARS Outpatient Count (in mn) Inpatient Count (in '000) Aster DM - Revenue from Operations (INR Cr) 8.7 7,963 7.8 218 6.7 7.0 202 6,721 5,931 5.6 158 5,250 4.2 125 3,876 3.4 104 2,871 7.0 85 5,762 6,437 6.3 192 163 - - - - - - - - - - - - FY14 FY15 FY16 FY17 FY18 FY19 FY20

  12. Slide 12: Aster – Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 11

  13. Slide 13: Aster - An Integrated Healthcare Provider

    Aster - An Integrated Healthcare Provider FY19 Operational Information 1,700+ 2,18,000+ Cardiovascular IP Discharges Surgeries ~5.6 mn 14,800+ 500+ Clinic OPD Visits General Bariatric Surgeries Surgeries Clinics $ 1 ₹6 0% 1200+ Joint 1,100+ ~ 9.6 mn Replacements Spine Surgeries Pharmacy Visits 9,600

  14. Slide 14: Aster – A Healthcare Ecosystem

    Aster – A Healthcare Ecosystem  Aster, over 30 years, has created a healthcare eco-system across two geographical regions  In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care  For complex tertiary car

  15. Slide 15: GCC Healthcare – Unique Traits

    GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat Population (mn) and working age population Expat% -> ~80% ~70% ~45% ~30% Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) 32.0  Due to lower % of old

  16. Slide 16: Aster - Awards & Service Excellence

    Aster - Awards & Service Excellence “The Sheikh Khalifa Excellence Award” JCI Accreditation Padma Shri Award (2018) Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Women & Children Hospital,Aster Me

  17. Slide 17: Key Highlights – FY20 Q3 (1/2)

    Key Highlights – FY20 Q3(1/2) Awards & Accreditations  Aster DM Healthcare presented with The CSR Label awarded by Dubai Chamber of Commerce & Industry (DCCI), the first in the region that builds on international standards while ensuring local relevance and is awarded to select companies on meeting

  18. Slide 18: Key Highlights – FY20 Q3 (2/2)

    Key Highlights – FY20 Q3 (2/2) Clinical Highlights  ECPR was successfully used at Aster Medcity for treating a patient who suffered from cardiac arrest outside a hospital for first time in India  Aster CMI carried out a paediatric to adult renal transplant from a 4-year-old child to 60-year-old ma

  19. Slide 19: Aster – Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 18

  20. Slide 20: Revenue and Profitability Snapshot – FY20 Q3

    Revenue and Profitability Snapshot – FY20 Q3 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ₹ 2150 ₹ 2322 ₹ 263 ₹ 314 ₹ 100 ₹ 155 6.7% 13.5% 12.2% 4.7% FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3  Constant currency growth of Revenue, EBITDA and Adjusted PAT is ~9%, ~19% and

  21. Slide 21: Revenue and Profitability Snapshot – FY20 9M

    Revenue and Profitability Snapshot – FY20 9M Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ₹ 5762 ₹ 6437 ₹ 513 ₹ 652 ₹ 124 ₹ 200 10.1% 3.1% 8.9% 2.1% FY19 9m FY20 9m FY19 9m FY20 9m FY19 9m FY20 9m  Constant currency growth of Revenue, EBITDA and Adjusted PAT is ~11%, ~26% and

  22. Slide 22: Geography-wise Financial – Snapshot (1/2)

    Geography-wise Financial – Snapshot (1/2) GCC INDIA CONSOLIDATED FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 Revenue (₹) 1,817 Cr 1,895 Cr 334 Cr 427 Cr 2,150 Cr 2,322 Cr EBITDA (₹) 227 Cr 263 Cr 36 Cr 50 Cr 263 Cr 314 Cr PAT (₹) 99 Cr 151 Cr 1 Cr 4 Cr 100 Cr 155 Cr Notes: 1. Revenue and EBITDA

  23. Slide 23: Geography-wise Financial – Snapshot (2/2)

    Geography-wise Financial – Snapshot (2/2) GCC INDIA CONSOLIDATED FY19 9M FY20 9M FY19 9M FY20 9M FY19 9M FY20 9M Revenue (₹) 4,802 Cr 5,209 Cr 960 Cr 1,229 Cr 5,762 Cr 6,437 Cr EBITDA (₹) 429 Cr 520 Cr 83 Cr 132 Cr 513 Cr 652 Cr PAT (₹) 138 Cr 197 Cr (14) Cr 3 Cr 124 Cr 200 Cr Notes: 1. Revenue and

  24. Slide 24: Geography-wise Business – Snapshot (1/2)

    Geography-wise Business – Snapshot (1/2) GCC INDIA CONSOLIDATED FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 Total Capacity Beds 1,052 1,111 4,038 3,693 5,090 4,804 Operational Beds 872 920 2,928 2,608 3,800 3,528 ALOS (Days) 2.0 1.9 3.6 3.5 3.0 2.9 Occupancy3 59% 61% 63% 62% 62% 62% Outpatient V

  25. Slide 25: Geography-wise Business – Snapshot (2/2)

    Geography-wise Business – Snapshot (2/2) GCC INDIA CONSOLIDATED FY19 9M FY20 9M FY19 9M FY20 9M FY19 9M FY20 9M Total Capacity Beds 1,052 1,111 4,038 3,693 5,090 4,804 Operational Beds 872 920 2,928 2,608 3,800 3,528 ALOS (Days) 2.0 1.9 3.5 3.5 3.0 3.0 Occupancy4 57% 55% 62% 63% 61% 61% Outpatient V

  26. Slide 26: Segmental Performance FY20-Q3

    Segmental Performance FY20-Q3 Growth % Unallocate Unallocated India - India - GCC GCC d& GCC GCC & FY20 Q3 GCC Clinics Hospitals & Total GCC Clinics Hospitals & Total Hospitals Pharmacies Elimination Hospitals Pharmacies Elimination Clinics Clinics s s No. of Business Units (#) 12 107 236 H-13, C-9

  27. Slide 27: Segmental Performance FY20-9M

    Segmental Performance FY20-9M Unallocated India - Unallocated India - GCC GCC GCC GCC & FY20 9M GCC Clinics Hospitals & & Total GCC Clinics Hospitals & Total Hospitals Pharmacies Hospitals Pharmacies Elimination Clinics Eliminations Clinics s No. of Business Units (#) 12 107 236 H-13, C-9 NA 377 Ope

  28. Slide 28: Vintage-wise Performance FY20 9M

    Vintage-wise Performance FY209M GCC Hospitals - Revenue (INR Cr) GCC Clinics - Revenue (INR Cr) India Hospitals and Clinics - Revenue Consolidated - Revenue (INR Cr)* (INR Cr) 581 385 66 130 2,192 5,856 6,437 1,807 1,418 1,485 1,098 1,229 Established Units Ramp-up units Total Established Units Ramp-

  29. Slide 29: Maturity Wise Hospital Performance – GCC FY20 9M

    Maturity Wise Hospital Performance – GCC FY209M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 18% 28% ₹7.5 4 36% 0-3 Years ₹ 385 254 ₹ ~164,700 2% Over 3 Years 72% ₹ ~164,500 62% ₹286.6 8 82% ₹1,807 666 16% 12 ₹ 2,1

  30. Slide 30: Maturity Wise Hospital Performance – India FY20 9M

    Maturity Wise Hospital Performance – India FY209M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 13% ₹ (16) 0-3 Years 2 10% ₹ 127.6 331 ₹ ~23,600 66% 90% 87% ₹ ~27,700 62% ₹165 Over 3 Years 10 ₹1087.9 2,277 15% 12 ₹

  31. Slide 31: Financial Summary – Profitability Statement (1/2)

    Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY20 Q2 FY19 Q3 FY20 Q3 Gw% Revenue from operations 2,087 2,150 2,322 8% Material consumption 616 655 695 Doctors cost 474 456 501 Employee cost (excl. doctors) 428 411 410 Other expenses 294 272 298 EBITDAR 276 356 418 17%  FY2

  32. Slide 32: Financial Summary – Profitability Statement (2/2)

    Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY199M FY209M Grt% Revenue from operations 5,762 6,437 12% Material consumption 1,757 1,938 Doctors cost 1,270 1,440 Employee cost (excl. doctors) 1,173 1,243 Other expenses 788 858 EBITDAR 775 957 24% EBITDAR % 13.4% 14.9%  FY2

  33. Slide 33: Financial Summary – Key Financial Ratios & Debts

    Financial Summary – Key Financial Ratios & Debts As at Mar 31, As at Dec 31, India (in INR Cr) 2019 2019 Debt 367 408 Less: Cash, Bank Balance and Current Investments 125 58 Net Debt 242 350 As at Mar 31, As at Dec 31, GCC (in USD mn) 2019 2019 Debt 333 379 Less: Cash, Bank Balance and Current Inves

  34. Slide 34: Financial Summary – INDAS116 Impact FY20Q3

    Financial Summary – INDAS116 Impact FY20Q3 GCC India Consolidated FY20 Q3 - FY20 Q3 - FY20 Q3 - before before before Particulars (INR Cr) FY19 Q3 INDAS116 INDAS 116 FY20 Q3 FY19 Q3 INDAS116 INDAS 116 FY20 Q3 FY19 Q3 INDAS116 INDAS 116 FY20 Q3 Revenue 1,816.6 1,894.7 - 1,894.7 333.5 427.0 - 427.0 2,1

  35. Slide 35: Financial Summary – INDAS116 Impact FY20 9M

    Financial Summary – INDAS116 Impact FY209M GCC India Consolidated FY20 9m - FY20 9m - FY20 9m - before before before Particulars (INR Cr) FY19 9m INDAS116 INDAS 116 FY20 9m FY19 9m INDAS116 INDAS 116 FY20 9m FY19 9m INDAS116 INDAS 116 FY20 9m Revenue 4,801.7 5,208.6 5,208.6 960.0 1,228.6 1,228.6 5,7

  36. Slide 36: Pipeline Projects

    Pipeline Projects Expected Completion Owned / Hospitals - GCC Location Type Planned Beds Stage Year Leased/O&M Aster Hospital Sonapur, Dubai, UAE Greenfield 41 Q4 FY 2020 Construction Leased Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2021 Construction Leased Greenfield Aster Hospital Muscat, Om

  37. Slide 37: Strategy and Leadership

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 36

  38. Slide 38: ADMHL – Strategy & Outlook (1/2)

    ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations/mar

  39. Slide 39: ADMHL – Strategy & Outlook (2/2)

    ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant dema

  40. Slide 40: India Strategy

    India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25% East

  41. Slide 41: Aster Leadership Team

    Aster Leadership Team Dr. Azad Moopen Dr. Harish Pillai Veneeth Purushotaman Chairman and Managing Director Chief Executive Officer – India Chief Information Officer Alisha Moopen Jobilal M. Vavachan Chief Executive Officer – Chief Executive Officer, Aster Fara Siddiqi GCC Hospitals & Clinics Pharma

  42. Slide 42: Aster Board of Directors

    Aster Board of Directors strategy andleadership Ravi Prasad Daniel James Dr. Azad Moopen Independent Director Snyder Chairman and Managing Director Independent Director Alisha Moopen Dr Layla Mohamed Suresh M. Non-Executive Director Al-Marzooqi Kumar Independent Director Independent Director Daniel

  43. Slide 43: www.asterdmhealthcare.com

    www.asterdmhealthcare.com

Aster DM Healthcare — Q3 FY20 Earnings Presentation on 6ix